2022
DOI: 10.1016/j.bioactmat.2022.01.033
|View full text |Cite
|
Sign up to set email alerts
|

Microcarriers in application for cartilage tissue engineering: Recent progress and challenges

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
22
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(22 citation statements)
references
References 377 publications
0
22
0
Order By: Relevance
“…Over the last few decades, researchers and scientists have attempted to fulfil the demands [1] of osteoarthritic patients [2,3] with an articular cartilage scaffold [4,5] equipped with requisite strength [6,7], cell growth factors [8][9][10], and anti-inflammatory properties [11,12]. Unfortunately, they invented biomaterials, such as hydrogels and their derivatives, that were equipped with the carriers of cell growth factors [13] and anti-inflammatory properties [14] but without the requisite strengths [15].…”
Section: Introductionmentioning
confidence: 99%
“…Over the last few decades, researchers and scientists have attempted to fulfil the demands [1] of osteoarthritic patients [2,3] with an articular cartilage scaffold [4,5] equipped with requisite strength [6,7], cell growth factors [8][9][10], and anti-inflammatory properties [11,12]. Unfortunately, they invented biomaterials, such as hydrogels and their derivatives, that were equipped with the carriers of cell growth factors [13] and anti-inflammatory properties [14] but without the requisite strengths [15].…”
Section: Introductionmentioning
confidence: 99%
“…In recent studies, decellularized cartilage matrices, bone, ureter, umbilical cord, and dermal tissues have been used as scaffolds in tissue engineering (19,20). In this study, the decellularized matrix of the human gingiva was used as a scaffold to induce migration and cell differentiation due to its high levels of collagen and the presence of various cytokeratins in its connective tissue.…”
Section: Resultsmentioning
confidence: 99%
“… Preparative ​technique Merits Demerits Application Microsphere-drug ​combination Ref. Emulsion-solidication Large-scale production, simple operation Wide particle size Oncotherapy Neuralrepair TPP/chitosan/PLGA-NGF Microspheres 5-Fluorouracil loaded biodegradable magnetic Microspheres Polysaccharidebased porous microsphere (PPM) [ 88 , 188 , 189 ] Microfluidics Unique analytical performance, smaller volume, good monodispersity Low production efficiency Oncotherapy 5-Fu loaded CS microspheres [ 30 , 35 ] Mold method Low cost, simple operation Complex synthesis process Protein separation Monodisperse porous silica microspheres [ 58 , 62 , 63 ] Microfluidic electrospray Uniform size and good monodispersity Low production efficiency Skin wounds Novel drug-loaded methacryloyl chondroitin sulfate (CSMA) microspheres [67, 196] Spray drying Simple and stable Limited range of polymers Gastropathy Chitosan-based microspheres [ 75 ] Self-assembly method Simple production technology, mild reaction conditions, and suitability for hydrophilic and hydrophobic drugs Size and monodispersity need to be improved Oncotherapy Paclitaxel-loaded silk fibroin nanospheres [ 78 ] Phase separation method For water-soluble drugs, easy to prepare in batches Difficult to remove organic solvents Arthritis Loaded sPL sustained-release microspheres [ 206 ] Membrane emulsification method...…”
Section: Processing Methods Of Microspheresmentioning
confidence: 99%
“…During the preparation of microspheres, different emulsions can be selected depending on the nature of the wrapped drug ( Fig. 1 A) [ 29 , 30 ].
Fig.
…”
Section: Processing Methods Of Microspheresmentioning
confidence: 99%
See 1 more Smart Citation